We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABVX
801
Abivax
ABVX
$10.9B
| $5.51M | 0.01% |
49,516
+24,710
| +100% | +$2.92M |
|
802
Ovintiv
OVV
$16.8B
| $5.51M | 0.01% |
92,862
-5,102
| -5% | -$246K |
|
803
Southern Company
SO
$107B
| $5.48M | 0.01% |
56,769
-10,879
| -16% | -$1.01M |
|
|
MPLT
804
MapLight Therapeutics
MPLT
$587M
| $5.44M | 0.01% |
267,746
+119,816
| +81% | +$2.14M |
|
805
UiPath
PATH
$7.31B
| $5.43M | 0.01% |
489,370
+2,156
| +0.4% | +$27.5K |
|
806
NetEase
NTES
$83.6B
| $5.42M | 0.01% |
48,412
-21,535
| -31% | -$2.67M |
|
807
Doximity
DOCS
$3.99B
| $5.4M | 0.01% |
231,958
-103,922
| -31% | -$3.24M |
|
|
SW
808
Smurfit Westrock
SW
$25.4B
| $5.38M | 0.01% |
135,520
+125,797
| +1,294% | +$5.43M |
|
809
Kymera Therapeutics
KYMR
$8.59B
| $5.37M | 0.01% |
64,467
-308
| -0.5% | -$24.4K |
|
810
PVH
PVH
$4.09B
| $5.36M | 0.01% |
76,883
+76,161
| +10,549% | +$5M |
|
811
Itaú Unibanco
ITUB
$90.3B
| $5.36M | 0.01% |
639,906
+201,146
| +46% | +$1.68M |
|
812
Brown & Brown
BRO
$23.8B
| $5.33M | 0.01% |
81,749
-196,190
| -71% | -$14.1M |
|
813
Equitable Holdings
EQH
$13.2B
| $5.22M | 0.01% |
137,503
-161,251
| -54% | -$6.91M |
|
814
Duke Energy
DUK
$96.9B
| $5.18M | 0.01% |
39,535
-5,740
| -13% | -$718K |
|
815
Amcor
AMCR
$21.8B
| $5.15M | 0.01% |
129,661
+69,191
| +114% | +$3.06M |
|
816
Urban Outfitters
URBN
$6.75B
| $5.08M | 0.01% |
80,156
-288
| -0.4% | -$19.8K |
|
817
WSFS Financial
WSFS
$4.21B
| $5.01M | 0.01% |
76,606
-3,733
| -5% | -$235K |
|
818
GeneDx Holdings
WGS
$2.1B
| $4.97M | 0.01% |
77,369
+18,911
| +32% | +$1.72M |
|
819
Tyra Biosciences
TYRA
$1.93B
| $4.94M | 0.01% |
128,860
-919
| -0.7% | -$29.8K |
|
|
QXO
820
QXO Inc
QXO
$15.9B
| $4.92M | 0.01% |
253,290
+244,901
| +2,919% | +$5.6M |
|
821
Petrobras
PBR
$121B
| $4.89M | 0.01% |
235,581
+81,261
| +53% | +$1.3M |
|
822
Check Point Software Technologies
CHKP
$12.7B
| $4.88M | 0.01% |
34,185
-192,423
| -85% | -$32.2M |
|
823
Vale
VALE
$63.1B
| $4.88M | 0.01% |
306,605
-99,800
| -25% | -$1.56M |
|
824
Korn Ferry
KFY
$4.23B
| $4.86M | 0.01% |
77,164
-220
| -0.3% | -$14.2K |
|
825
Cinemark Holdings
CNK
$4.41B
| $4.81M | 0.01% |
168,625
-61
| -0% | -$1.56K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.